Virtual
Venable partners Valerie Cohen and Ha Kung Wong, along with Jeffrey Cerio, General Counsel of Atomwise, and Austin Hay, Associate Director at Berkeley Research Group, will take a deep dive into the Inflation Reduction Act (IRA) and discover its potential impact on the pharmaceutical industry.
The panelists will summarize the provisions of the IRA relevant to the pharmaceutical industry and discuss the possible effects of Medicare and inflation price controls.
Topics will include:
- Provisions of the IRA Relevant to the Pharmaceutical Industry
- Potential Impact on Drug Prices and Spending in the Life Sciences Industry
- Legal Challenges to the IRA
- Intersection with Regulatory and Patent Exclusivities / Value
- Potential Impact on Patent Litigation